Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future Directions.

Ball G, Kurek R, Hendrickson BA, Buchanan J, Wang WW, Duke SP, Bhattacharyya A, Li M, O'Brien D, Weigel J, Wang W, Jiang Q, Ahmad F, Seltzer JH, Herrero-Martinez E, Tremmel L.

Ther Innov Regul Sci. 2019 May 12:2168479019841314. doi: 10.1177/2168479019841314. [Epub ahead of print]

PMID:
31079486
2.

Monitoring Drug Safety in Rheumatoid Arthritis Prevention Trials.

Neagu MR, Weinreich MA, Doan TT, Hendrickson BA.

Clin Ther. 2019 Jul;41(7):1366-1375. doi: 10.1016/j.clinthera.2019.04.016. Epub 2019 May 9.

PMID:
31078317
3.

Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis.

Ryan C, Sobell JM, Leonardi CL, Lynde CW, Karunaratne M, Valdecantos WC, Hendrickson BA.

Am J Clin Dermatol. 2018 Jun;19(3):437-447. doi: 10.1007/s40257-017-0341-6.

4.

Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study.

Wang SX, Abramson SB, Attur M, Karsdal MA, Preston RA, Lozada CJ, Kosloski MP, Hong F, Jiang P, Saltarelli MJ, Hendrickson BA, Medema JK.

Osteoarthritis Cartilage. 2017 Dec;25(12):1952-1961. doi: 10.1016/j.joca.2017.09.007. Epub 2017 Sep 28.

5.

RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study.

Tripp CS, Cuff C, Campbell AL, Hendrickson BA, Voss J, Melim T, Wu C, Cherniack AD, Kim K.

Adv Ther. 2017 Jun;34(6):1364-1381. doi: 10.1007/s12325-017-0525-8. Epub 2017 Apr 28.

6.

Pneumonia With Chest Wall Invasion in a School-Aged Child.

Nash CB, Hendrickson BA, Alexander KA.

J Pediatric Infect Dis Soc. 2014 Dec;3(4):e42-4. doi: 10.1093/jpids/piu002. Epub 2014 Feb 16. No abstract available.

PMID:
26625462
7.

Polymeric immunoglobulin receptor in intestinal immune defense against the lumen-dwelling protozoan parasite Giardia.

Davids BJ, Palm JE, Housley MP, Smith JR, Andersen YS, Martin MG, Hendrickson BA, Johansen FE, Svärd SG, Gillin FD, Eckmann L.

J Immunol. 2006 Nov 1;177(9):6281-90.

8.

Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.

McNeal MM, Stone SC, Basu M, Bean JA, Clements JD, Hendrickson BA, Choi AH, Ward RL.

Virology. 2006 Mar 15;346(2):338-47. Epub 2006 Jan 10.

9.

Gastric inflammation as a feature of ulcerative colitis.

Hendrickson BA.

J Pediatr Gastroenterol Nutr. 2003 Sep;37(3):228-9. No abstract available.

PMID:
12960641
10.

Enteric flora and lymphocyte-derived cytokines determine expression of heat shock proteins in mouse colonic epithelial cells.

Kojima K, Musch MW, Ren H, Boone DL, Hendrickson BA, Ma A, Chang EB.

Gastroenterology. 2003 May;124(5):1395-407.

PMID:
12730879
11.

Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction.

Liu TS, Musch MW, Sugi K, Walsh-Reitz MM, Ropeleski MJ, Hendrickson BA, Pothoulakis C, Lamont JT, Chang EB.

Am J Physiol Cell Physiol. 2003 Apr;284(4):C1073-82. Epub 2002 Dec 18.

12.

Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.

Schwartz-Cornil I, Benureau Y, Greenberg H, Hendrickson BA, Cohen J.

J Virol. 2002 Aug;76(16):8110-7.

13.

MMR vaccination, ileal lymphoid nodular hyperplasia, and pervasive develop-mental disorder.

Hendrickson BA, Turner JR.

Lancet. 2002 Jun 15;359(9323):2051-2. No abstract available.

PMID:
12086756
14.

Clinical aspects and pathophysiology of inflammatory bowel disease.

Hendrickson BA, Gokhale R, Cho JH.

Clin Microbiol Rev. 2002 Jan;15(1):79-94. Review.

15.

Surgical stress shifts the intestinal Escherichia coli population to that of a more adherent phenotype: role in barrier regulation.

Rocha F, Laughlin R, Musch MW, Hendrickson BA, Chang EB, Alverdy J.

Surgery. 2001 Jul;130(1):65-73. Erratum in: Surgery 2001 Oct;130(4):592.

PMID:
11436014
16.

Decreased vaginal disease in J-chain-deficient mice following herpes simplex type 2 genital infection.

Hendrickson BA, Guo J, Brown I, Dennis K, Marcellino D, Hetzel J, Herold BC.

Virology. 2000 May 25;271(1):155-62.

17.
18.

Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.

Epstein SL, Lo CY, Misplon JA, Lawson CM, Hendrickson BA, Max EE, Subbarao K.

J Immunol. 1997 Feb 1;158(3):1222-30.

PMID:
9013963
19.

Lack of association of secretory component with IgA in J chain-deficient mice.

Hendrickson BA, Rindisbacher L, Corthesy B, Kendall D, Waltz DA, Neutra MR, Seidman JG.

J Immunol. 1996 Jul 15;157(2):750-4.

PMID:
8752925
20.

Altered hepatic transport of immunoglobulin A in mice lacking the J chain.

Hendrickson BA, Conner DA, Ladd DJ, Kendall D, Casanova JE, Corthesy B, Max EE, Neutra MR, Seidman CE, Seidman JG.

J Exp Med. 1995 Dec 1;182(6):1905-11.

21.

Induction of the FK506-binding protein, FKBP13, under conditions which misfold proteins in the endoplasmic reticulum.

Bush KT, Hendrickson BA, Nigam SK.

Biochem J. 1994 Nov 1;303 ( Pt 3):705-8. Erratum in: Biochem J 1995 Feb 1;305(Pt 3):1031.

22.

Structural organization of the genes encoding human and murine FK506-binding protein (FKBP) 13 and comparison to FKBP1.

Hendrickson BA, Zhang W, Craig RJ, Jin YJ, Bierer BE, Burakoff S, DiLella AG.

Gene. 1993 Dec 8;134(2):271-5.

PMID:
7505249

Supplemental Content

Loading ...
Support Center